Vera Therapeutics, Inc. VERA

Set alert

30.71 USD +0.46 (+1.52%)

At closeNov 3, 2026, 5:30 PM EST

31.31 +0.60 +1.95%

After hours · Nov 3, 5:30 PM ET

29.90 Day range 31.19

23.05 52-week range 56.05

Held by insiders 1.01%

Held by institutions 118.22%

Float held by institutions 119.43%

Institutions 315

Top institutional holders
Holder	% held	Shares	Value	Reported
Blackrock Inc.	7.98%	5,747,760	176.51M	Jun 29, 2026
Avoro Capital Advisors LLC	7.94%	5,723,888	175.78M	Jun 29, 2026
State Street Corporation	5.76%	4,148,786	127.41M	Jun 29, 2026
Price (T.Rowe) Associates Inc	5.57%	4,012,936	123.24M	Jun 29, 2026
Deep Track Capital, Lp	5.55%	4,000,000	122.84M	Jun 29, 2026
Deerfield Management Company, L.P	5.43%	3,916,400	120.27M	Jun 29, 2026

Top mutual fund holders
Holder	% held	Shares	Value	Reported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund	2.68%	1,933,728	59.38M	Jun 29, 2026
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF	2.55%	1,834,397	56.33M	Sep 29, 2026
iShares Trust-iShares Russell 2000 ETF	2.30%	1,654,806	50.82M	Sep 29, 2026
T. Rowe Price New Horizons Fund, Inc.	1.41%	1,014,457	31.15M	Jun 29, 2026
Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund	1.21%	871,547	26.77M	Aug 30, 2026
T. Rowe Price Health Sciences Fund, Inc.	1.09%	784,306	24.09M	Jun 29, 2026

VERA insiders
Insider	Relation	Latest transaction	Date	Shares held
BOMAN NANCY LEE M.D., PH.D.	Officer	Stock Award(Grant)	Aug 2, 2026	44,987
BRENNER ROBERT	Officer	Sale	Feb 22, 2026	50,947
CARTER JASON S	Officer	Sale	Nov 20, 2025	49,136
ENRIGHT PATRICK G.	Director	Purchase	Dec 10, 2025	5,400,090
FORDYCE MARSHALL	Chief Executive Officer	Conversion of Exercise of derivative security	Sep 14, 2026	235,244
GRANT SEAN	Chief Financial Officer	Sale	Feb 22, 2026	119,181

Held by funds